ZOLL® Medical Corporation, an Asahi Kasei Group Company that
manufactures medical devices and related software solutions, today
announced it has signed a definitive agreement to purchase Cardiac
Science Corporation (CSC), a leading provider of automated external
defibrillators (AEDs), related services, and accessories. CSC is a
portfolio company of Aurora Resurgence, a Los Angeles-based private
equity investment firm.
“We are excited about the alignment of our two companies and our
combined ability to put life-saving technology in the hands of more lay
rescuers and first responders answering medical emergencies,” said
Elijah A. White, President of ZOLL Resuscitation. “ZOLL and Cardiac
Science have been delivering AED solutions for the better part of two
decades. As we look to the future together, our combined organization
will provide more choices to current and future customers. This includes
continuing to actively promote, market, and supply the Powerheart®
line of AEDs and Rescue Ready® services in addition to our
ZOLL AEDs and PlusTrac™
program management. Moving forward, ZOLL plans to continue ongoing
development and to introduce new products for both Powerheart and ZOLL
brands.”
“Joining ZOLL is the right opportunity for our business, our people, and
our customers,” said Dev Kurdikar, President and CEO of Cardiac Science.
“We are enthusiastic that our combined portfolios will be able to
address a greater range of needs for our customers and look forward to
accelerated innovation to meet persistent needs in the community for
these vital emergency services. By expanding the reach of our current
and future line of Powerheart AEDs, we will be able to further fulfill
our mission of saving lives.”
White highlighted that one of the benefits of joining forces is the
expansion of ZOLL’s lifesaving AED management programs to a larger
number of AEDs. ZOLL’s AED Link™ connects first responders with the
closest available AED. Today, publicly available AEDs are sometimes not
retrieved and used because bystanders cannot see them and 9-1-1
dispatchers are unaware they are nearby. ZOLL’s technology enables
dispatchers to communicate the locations of registered AEDs to callers
reporting potential sudden cardiac arrest incidents. With the addition
of Cardiac Science to the AED Link program more 9-1-1 agencies will be
able to help put AEDs in the hands of laypersons and first responders to
support life-saving action.
Kurdikar added, “Cardiac Science has an exciting pipeline of innovative
products that are anticipated to be launched beginning this year. These
new technologies, which advance ease of use or performance, can be
deployed in ZOLL AEDs and thus benefit more SCA victims across the
world.”
“Combining ZOLL’s PlusTrac program management and Cardiac Science’s
Rescue Ready Services offering will expand ZOLL’s database of AED
information,” White added, “and in so doing, improve first responder
access to AEDs and improve the response to victims of cardiac arrest.”
The acquisition is subject to regulatory approval and other customary
closing conditions. Additional terms of the agreement are not being
disclosed at this time.
About Sudden Cardiac Arrest
Sudden cardiac arrest (SCA), an abrupt disruption of the heart’s
function, which causes a lack of blood flow to vital organs, claims more
than 350,000 lives each year in the U.S. It is the leading cause of
unexpected death in the world and strikes without warning. Timing is
critical to survival. If a victim does not receive CPR and early
defibrillation from an AED, chances of survival decrease 10% with each
passing minute.
About Cardiac Science Corporation
Cardiac Science develops, manufactures, and markets automated external
defibrillators (AEDs) and related parts, components and accessories. The
company also provides a comprehensive portfolio of training,
maintenance, and support services for AED customers. Cardiac Science has
executive offices in Deerfield, Wisconsin. The company has operations in
North America, Europe, and Asia and has an installed base of over
500,000 units in nearly 100 countries worldwide. Cardiac Science is a
portfolio company of Los Angeles-based Aurora Resurgence, a leading
private equity firm focused on investing in middle market companies. For
information, call 1.800.426.0337 or contact info@cardiacscience.com.
About ZOLL Medical Corporation
ZOLL Medical Corporation, an Asahi Kasei Group company, develops and
markets medical devices and software solutions that help advance
emergency care and save lives, while increasing clinical and operational
efficiencies. With products for defibrillation and monitoring,
circulation and CPR feedback, data management, fluid resuscitation,
therapeutic temperature management, and ventilation, ZOLL provides a
comprehensive set of technologies that help clinicians, EMS and fire
professionals, and lay rescuers treat victims needing resuscitation and
acute critical care. For more information, visit www.zoll.com.
About Asahi Kasei
The Asahi Kasei Group is a diversified group of companies led by holding
company Asahi Kasei Corp., with operations in the material, homes, and
health care business sectors. Its health care operations include devices
and systems for acute critical care, dialysis, therapeutic apheresis,
transfusion, and manufacture of biotherapeutics, as well as
pharmaceuticals and diagnostic reagents. With more than 30,000 employees
around the world, the Asahi Kasei Group serves customers in more than
100 countries. For more information, visit www.asahi-kasei.co.jp/asahi/en/.
Copyright © 2019 ZOLL Medical Corporation. All rights reserved. AED
Link, PlusTrac and ZOLL are trademarks and/or registered trademarks of
ZOLL Medical Corporation in the United States and/or other countries.
Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All
other trademarks are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190611005140/en/